The Department of Pediatrics at Memorial Sloan Kettering Cancer Center offers a one-to-two-year post-specialty clinical and research fellowship program intended for physicians trained in pediatric hematology-oncology who seek in-depth exposure to tumor immunotherapy. The goal of this fellowship program is to train the fellow to translate immunotherapy strategies from the laboratory to the patient, including but not limited to clinical trial design, protocol development, Investigational New Drug (IND) application, and execution of clinical trials. The clinical focus will primarily be neuroblastoma, with occasional overlap with sarcoma, brain tumors and certain leukemias. Applicants for this program must have completed their residency training in pediatrics, plus fellowship training in pediatric hematology/oncology or pediatric neuro-oncology.
Length of Program
One to Two Years
Applicants should have completed training in an ACGME-accredited Pediatric Hematology-Oncology Fellowship Program and must have completed USMLE Steps I, II, and III. Foreign medical graduates with equivalent qualifications are also eligible to apply and must have completed all three of the USMLE examinations, a CSA exam, and hold a valid ECFMG certificate. For further information and application, please contact David Meni.